InMed Pharmaceuticals Inc. Quarterly Operating Margin in % from Q2 2023 to Q3 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Operating Margin history and growth rate from Q2 2023 to Q3 2023.
  • InMed Pharmaceuticals Inc. Operating Margin for the quarter ending September 30, 2023 was -148 %.
  • InMed Pharmaceuticals Inc. annual Operating Margin for 2023 was -192 %, a 88.7% increase from 2022.
Operating Margin, Quarterly (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -148 Jul 1, 2023 Sep 30, 2023
Q2 2023 -192 Apr 1, 2023 Jun 30, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.